rabeprazole has been researched along with Clostridioides difficile Infection in 1 studies
Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clostridium perfringens infections affect food safety, human health, and the development of the poultry feed industry." | 1.91 | Repurposing rabeprazole sodium as an anti-Clostridium perfringens drug by inhibiting perfringolysin O. ( Deng, L; Deng, X; Feng, H; Guo, Z; Li, Q; Liu, H; Liu, Y; Qiu, J; Wang, G, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, G | 1 |
| Liu, Y | 1 |
| Deng, L | 1 |
| Liu, H | 1 |
| Deng, X | 1 |
| Li, Q | 1 |
| Feng, H | 1 |
| Guo, Z | 1 |
| Qiu, J | 1 |
1 other study available for rabeprazole and Clostridioides difficile Infection
| Article | Year |
|---|---|
Repurposing rabeprazole sodium as an anti-Clostridium perfringens drug by inhibiting perfringolysin O.
Topics: Clostridium Infections; Clostridium perfringens; Drug Repositioning; Hemolysin Proteins; Humans; Rab | 2023 |